146 related articles for article (PubMed ID: 24780601)
1. Lead optimization of dual tubulin and Hsp27 inhibitors.
Zhong B; Lama R; Kulman DG; Li B; Su B
Eur J Med Chem; 2014 Jun; 80():243-53. PubMed ID: 24780601
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and anticancer mechanism investigation of dual Hsp27 and tubulin inhibitors.
Zhong B; Chennamaneni S; Lama R; Yi X; Geldenhuys WJ; Pink JJ; Dowlati A; Xu Y; Zhou A; Su B
J Med Chem; 2013 Jul; 56(13):5306-20. PubMed ID: 23767669
[TBL] [Abstract][Full Text] [Related]
3. Discovery and molecular modeling of novel 1-indolyl acetate--5-nitroimidazole targeting tubulin polymerization as antiproliferative agents.
Duan YT; Sang YL; Makawana JA; Teraiya SB; Yao YF; Tang DJ; Tao XX; Zhu HL
Eur J Med Chem; 2014 Oct; 85():341-51. PubMed ID: 25105922
[TBL] [Abstract][Full Text] [Related]
4. Identification of a class of novel tubulin inhibitors.
Yi X; Zhong B; Smith KM; Geldenhuys WJ; Feng Y; Pink JJ; Dowlati A; Xu Y; Zhou A; Su B
J Med Chem; 2012 Apr; 55(7):3425-35. PubMed ID: 22435708
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis and anticancer properties of IsoCombretaQuinolines as potent tubulin assembly inhibitors.
Khelifi I; Naret T; Renko D; Hamze A; Bernadat G; Bignon J; Lenoir C; Dubois J; Brion JD; Provot O; Alami M
Eur J Med Chem; 2017 Feb; 127():1025-1034. PubMed ID: 28166995
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, anti-cancer evaluation of benzenesulfonamide derivatives as potent tubulin-targeting agents.
Yang J; Yang S; Zhou S; Lu D; Ji L; Li Z; Yu S; Meng X
Eur J Med Chem; 2016 Oct; 122():488-496. PubMed ID: 27423028
[TBL] [Abstract][Full Text] [Related]
7. Triazole tethered C5-curcuminoid-coumarin based molecular hybrids as novel antitubulin agents: Design, synthesis, biological investigation and docking studies.
Singh H; Kumar M; Nepali K; Gupta MK; Saxena AK; Sharma S; Bedi PMS
Eur J Med Chem; 2016 Jun; 116():102-115. PubMed ID: 27060762
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, biological evaluation, and molecular docking studies of novel 1-benzene acyl-2-(1-methylindol-3-yl)-benzimidazole derivatives as potential tubulin polymerization inhibitors.
Wang YT; Qin YJ; Yang N; Zhang YL; Liu CH; Zhu HL
Eur J Med Chem; 2015 Jun; 99():125-37. PubMed ID: 26070164
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis and biological evaluation of novel macrocyclic bisbibenzyl analogues as tubulin polymerization inhibitors.
Sun B; Li L; Hu QW; Xie F; Zheng HB; Niu HM; Yuan HQ; Lou HX
Eur J Med Chem; 2016 Oct; 121():484-499. PubMed ID: 27318123
[TBL] [Abstract][Full Text] [Related]
10. Fragment based group QSAR and molecular dynamics mechanistic studies on arylthioindole derivatives targeting the α-β interfacial site of human tubulin.
Tyagi C; Gupta A; Goyal S; Dhanjal J; Grover A
BMC Genomics; 2014; 15 Suppl 9(Suppl 9):S3. PubMed ID: 25521775
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological evaluation of curcumin inspired indole analogues as tubulin polymerization inhibitors.
Sri Ramya PV; Angapelly S; Guntuku L; Singh Digwal C; Nagendra Babu B; Naidu VGM; Kamal A
Eur J Med Chem; 2017 Feb; 127():100-114. PubMed ID: 28038323
[TBL] [Abstract][Full Text] [Related]
12. MT-4 suppresses resistant ovarian cancer growth through targeting tubulin and HSP27.
Pai HC; Kumar S; Shen CC; Liou JP; Pan SL; Teng CM
PLoS One; 2015; 10(4):e0123819. PubMed ID: 25874627
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of phenstatin/isocombretastatin-chalcone conjugates as potent tubulin polymerization inhibitors and mitochondrial apoptotic inducers.
Kamal A; Kumar GB; Vishnuvardhan MV; Shaik AB; Reddy VS; Mahesh R; Sayeeda IB; Kapure JS
Org Biomol Chem; 2015 Apr; 13(13):3963-81. PubMed ID: 25721862
[TBL] [Abstract][Full Text] [Related]
14. Novel Aldimine-Type Schiff Bases of 4-Amino-5-[(3,4,5-trimethoxyphenyl)methyl]-1,2,4-triazole-3-thione/thiol: Docking Study, Synthesis, Biological Evaluation, and Anti-Tubulin Activity.
Ameri A; Khodarahmi G; Hassanzadeh F; Forootanfar H; Hakimelahi GH
Arch Pharm (Weinheim); 2016 Aug; 349(8):662-81. PubMed ID: 27320785
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis and molecular modeling of new 4-phenylcoumarin derivatives as tubulin polymerization inhibitors targeting MCF-7 breast cancer cells.
Batran RZ; Kassem AF; Abbas EMH; Elseginy SA; Mounier MM
Bioorg Med Chem; 2018 Jul; 26(12):3474-3490. PubMed ID: 29793751
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, anticancer activity and molecular docking studies on a series of heterocyclic trans-cyanocombretastatin analogues as antitubulin agents.
Penthala NR; Zong H; Ketkar A; Madadi NR; Janganati V; Eoff RL; Guzman ML; Crooks PA
Eur J Med Chem; 2015 Mar; 92():212-20. PubMed ID: 25557492
[TBL] [Abstract][Full Text] [Related]
17. Design and synthesis of substituted dihydropyrimidinone derivatives as cytotoxic and tubulin polymerization inhibitors.
Sana S; Tokala R; Bajaj DM; Nagesh N; Bokara KK; Kiranmai G; Lakshmi UJ; Vadlamani S; Talla V; Shankaraiah N
Bioorg Chem; 2019 Dec; 93():103317. PubMed ID: 31586714
[TBL] [Abstract][Full Text] [Related]
18. Design, Synthesis and Molecular Docking Studies of Novel Indole-Pyrimidine Hybrids as Tubulin Polymerization Inhibitors.
Hu MJ; Zhang B; Yang HK; Liu Y; Chen YR; Ma TZ; Lu L; You WW; Zhao PL
Chem Biol Drug Des; 2015 Dec; 86(6):1491-500. PubMed ID: 26177395
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis, and biological evaluation of new series of pyrrol-2(3H)-one and pyridazin-3(2H)-one derivatives as tubulin polymerization inhibitors.
Abdelbaset MS; Abdelrahman MH; Bukhari SNA; Gouda AM; Youssif BGM; Abdel-Aziz M; Abuo-Rahma GEA
Bioorg Chem; 2021 Feb; 107():104522. PubMed ID: 33317838
[TBL] [Abstract][Full Text] [Related]
20. Tubulin inhibitors: pharmacophore modeling, virtual screening and molecular docking.
Niu MM; Qin JY; Tian CP; Yan XF; Dong FG; Cheng ZQ; Fida G; Yang M; Chen HY; Gu YQ
Acta Pharmacol Sin; 2014 Jul; 35(7):967-79. PubMed ID: 24909516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]